鄰近類別 圖書 [2/4] 期刊論文 [48/49] 類別統計 近3年內發表的文件:0(0.00%) 含全文筆數:16(100.00%) 文件下載次數統計 下載大於0次:16(100.00%) 下載大於100次:16(100.00%) 檔案下載總次數:10811(22.36%) 最後更新時間: 2024-12-01 12:17 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 CYP1A2 genetic polymorphisms associ... Opioid receptor Mu1 genetic polymor... Genetic polymorphisms of CYP2C19 as... The genetic polymorphisms in ALDH2 ... Genetic polymorphisms in PXR associ... Factors associated with methylpheni... Patient and service provider effect... Characteristics associated with ben... The monitor of serum prolactin leve... New-onset diabetes mellitus associa...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-16 / 16. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2012-03	CYP1A2 genetic polymorphisms associated with antidepressant escitalopram metabolism and adverse reactions at early stage	Clinical Pharmacology and Therapeutics. 2012 Mar;91(Suppl. 1):S62.
2011-05	Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):71.
2011-05	The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction	Drug Metabolism Reviews. 2011 May;43(Suppl.1):26.
2011-05	Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine	Drug Metabolism Reviews. 2011 May;43(Suppl.1):25-26.
2011-05	Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients	Biological Psychiatry. 2011 May;69(9 Suppl.1):229S-230S.
2010-06-01	Patient and service provider effects on methylphenidate over-prescription among newly diagnosed attention deficit hyperactivity disorder (ADHD) children in Taiwan	American Journal of Epidemiology. 2010 Jun 1;171(Suppl. 11):S130.
2010-06-01	Factors associated with methylphenidate utilization among youngsters with newly diagnosed attention deficit hyperactivity disorder in Taiwan	American Journal of Epidemiology. 2010 Jun 1;171(Suppl. 11):S129.
2009-10	Cytochrome P-450 Isozyme 2C19 Genetic Polymorphisms are Associated with Plasma Concentrations of Escitalopram	Therapeutic Drug Monitoring. 2009 Oct;31(5):166.
2009-10	Prescription patterns and expenditure of long-term benzodiazepine treatment in elderly outpatients in Taiwan	Value in Health. 2009 Oct;12(7):A297.
2009-07	Multidimensional assessments of impulsivity in subjects with history of suicidal attempts	Comprehensive Psychiatry. 2009 Jul;50(4):315-321.
2008-07	The trend of benzodiazepine prescription in Taiwan, 2001-2004	International Journal of Neuropsychopharmacology. 2008 Jul;11(Suppl. 1):241-242.
2008-04	The monitor of serum prolactin level and related clinical observations among individuals with schizophrenia spectrum illnesses in a 12 weeks aripiprazole treatment	Biological Psychiatry. 2008 Apr;63(7):287S.
2007-05	Characteristics associated with benzodiazepine usage in elderly outpatients in Taiwan	Value in Health. 2007 May-Jun;10(3):A157.
2007-04	Association study of ADRA1A gene and obesity in people with chronic schizophrenia	Biological Psychiatry. 2007 Apr;61(8):S255-S256.
2006-09	Gender difference in interaction between ADRA2A gene and ADRB3 gene on bone density among schizophrenic patients with exposure to antipsychotics	European Neuropsychopharmacology. 2006 Sep;16(Suppl.4):S427.
2006-05	New-onset diabetes mellitus associated with use of atypical antipsychotics among schizophrenic patients in Taiwan	Value in Health. 2006 May-Jun;9(3):A65-A66.

顯示項目1-16 / 16. (共1頁) 1  每頁顯示[10|25|50]項目